Perspectives of future pharmacists on the potential for development and implementation of pharmacist prescribing in Qatar.
Adolescent
Adult
Attitude of Health Personnel
Community Pharmacy Services
/ trends
Cross-Sectional Studies
Drug Prescriptions
Education, Pharmacy
/ methods
Female
Forecasting
Humans
Male
Pharmacists
/ psychology
Professional Role
/ psychology
Program Development
/ methods
Qatar
/ epidemiology
Young Adult
Mixed-methods
Pharmacist prescribing
Pharmacy graduates
Pharmacy students
Qatar
Journal
International journal of clinical pharmacy
ISSN: 2210-7711
Titre abrégé: Int J Clin Pharm
Pays: Netherlands
ID NLM: 101554912
Informations de publication
Date de publication:
Feb 2020
Feb 2020
Historique:
received:
05
06
2019
accepted:
26
11
2019
pubmed:
4
1
2020
medline:
22
1
2021
entrez:
4
1
2020
Statut:
ppublish
Résumé
Background Pharmacists in many developed countries have been granted prescribing authorities under what is known as "non-medical prescribing" or "pharmacist prescribing". However, such prescribing privileges are not available in many developing countries. Objective The objective of this study was to determine the perspectives of future pharmacists (recent pharmacy graduates and pharmacy students) on pharmacist prescribing and its potential implementation in Qatar. Methods A convergent parallel mixed-methods design was used: (1) a cross-sectional survey using a pre-tested questionnaire and; (2) focus group discussions to allow for an in-depth understanding of the issue, with a focus on pharmacists prescribing competencies as well as barriers for its implementation. Main outcome measures Future pharmacists' perspectives and attitudes towards pharmacist prescribing in Qatar. Results The majority of the respondents (94.4%) indicated awareness of the prescribing competency related to selecting treatment options. Furthermore, the majority (92.4%) believed that pharmacists should undergo prescribing training and accreditation before been legally allowed to prescribe, a point that was reiterated in the focus group discussions. Participants generally expressed support for collaborative and supplementary prescribing models when developing prescribing frameworks for Qatar. Four categories emerged under the theme barriers to implementation of pharmacist prescribing: lack of prescribing competency, pharmacist mindset, lack of accessibility to patient records and counseling rooms, and diversity of education and training background. Conclusion The majority of recent pharmacy graduates and students were in favor of pharmacist prescribing been implemented in Qatar. However, a special training program was deemed necessary to qualify pharmacists to prescribe safely and effectively.
Identifiants
pubmed: 31898166
doi: 10.1007/s11096-019-00946-9
pii: 10.1007/s11096-019-00946-9
pmc: PMC7162834
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
110-123Subventions
Organisme : Qatar University
ID : QUCP-CPH-2018_2019-2
Références
Isasi F, Krofah E. The expanding role of pharmacists in a transformed health care system. Washington, D.C.: National Governors Association Center for Best Practices; January 13, 2015.
Blouin R, Adams M. The role of the pharmacist in health care. N C Med J. 2017;78(3):165–7.
pubmed: 28576952
Bradley C. The future role of pharmacists in primary care. Brit J Gen Pract. 2009;59(569):891–2.
Hoti K. An expanded prescribing role for pharmacists: an Australian perspective. Australas Med J. 2011;4(4):236–42.
pubmed: 23393515
pmcid: 3562903
Law M, Ma T, Fisher J, Sketris I. Independent pharmacist prescribing in Canada. Can Pharm J. 2012;145(1):17–23.
Faruquee C, Guirguis L. A scoping review of research on the prescribing practice of Canadian pharmacists. Can Pharm J. 2015;148(6):325–48.
Yuksel N, Eberhart G, Bungard T. Prescribing by pharmacists in Alberta. Am J Health Syst Pharm. 2008;65(22):2126–32.
pubmed: 18997141
Emmerton L, Marriott J, Bessell T, Nissen L, Dean L. Pharmacists and prescribing rights: review of international developments. J Pharm Pharmaceut Sci. 2005;8:217–25.
Auta A, Strickland-Hodge B, Maz J. Stakeholders’ views on granting prescribing authority to pharmacists in Nigeria: a qualitative study. Int J Clin Pharm. 2016;38(4):960–7.
pubmed: 27194098
Cope L, Abuzour A, Tully M. Nonmedical prescribing: where are we now? Ther Adv Drug Saf. 2016;7(4):165–72.
pubmed: 27493720
pmcid: 4959632
Stewart D, Jebara T, Cunningham S, Awaisu A, Pallivalapila A, MacLure K. Future perspectives on nonmedical prescribing. Ther Adv Drug Saf. 2017;8(6):183–97.
pubmed: 28607668
pmcid: 5455843
Raghunandan R, Tordoff J, Smith A. Non-medical prescribing in New Zealand: an overview of prescribing rights, service delivery models and training. Ther Adv Drug Saf. 2017;8(11):349–60.
pubmed: 29090084
pmcid: 5638172
Tonna AP, Stewart D, McCaig D. An international overview of some pharmacist prescribing models. J Malta Coll Pharm Pract. 2008;14:20–6.
Hoti K, Hughes J, Sunderland B. Training of pharmacist prescribers. Int J Pharm Pract. 2014;22:38–46.
pubmed: 23419013
Stewart D, MacLure K, George J. Educating non-medical prescribers. Br J Clin Pharmacol. 2012;74:662–7.
pubmed: 22300374
pmcid: 3477334
Tonna AP, Stewart D, West B, McCaig D. Pharmacist prescribing in the UK: a literature review of current practice and research. J Clin Pharm Ther. 2007;32(6):545–56.
pubmed: 18021331
Charrois T, Rosenthal M, Hoti K, Hughes C. Pharmacy student perceptions of pharmacist prescribing: a comparison study. Pharmacy. 2013;1(2):237–47.
Amirault P. Update on pharmacists prescribing. Pharm Post. 2006;14:6–8.
Hughes C, Makowsky M, Sadowski C, Schindel T, Yuksel N, Guirguis L. What prescribing means to pharmacists: a qualitative exploration of practising pharmacists in Alberta. Int J Pharm Pract. 2013;22(4):283–91.
Law MR, Ma T, Fisher J, Sketris IS. Independent pharmacist prescribing in Canada. Can Pharm J. 2012;145:17–23.
Emmerton L, Marriott J, Bessell T, Nissen L, Dean L. Pharmacists and prescribing rights: review of international developments. J Pharm Pharm Sci. 2005;8:217–25.
pubmed: 16124933
Nissen L. Pharmacist prescribing: what are the next steps? Am J Health Syst Pharm. 2011;68:2357–61.
pubmed: 22135062
Weeks G, George J, Maclure K, Stewart D. Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care. Cochrane Db Syst Rev. 2016;11:CD011227
Mansell K, Bootsman N, Kuntz A, Taylor J. Evaluating pharmacist prescribing for minor ailments. Int J Pharm Pract. 2015;23:95–101.
pubmed: 24930999
Al Hamarneh YN, Charrois T, Lewanczuk R, Tsuyuki T. Phar-macist intervention for glycaemic control in the community (the RxING study). BMJ Open. 2013;3(e003154):23.
Law MR, Morgan SG, Majumdar SR, Lynd LD, Marra CA. Effects of pre-scription adaptation by pharmacists. BMC Health Serv Res. 2010;10:313.
pubmed: 21083922
pmcid: 2994856
Tsuyuki RT, Houle SK, Charrois TL, Kolber MR, Rosenthal MM, Lewanczuk R, et al. A randomized trial of the effect of pharmacist prescribing on improving blood pres-sure in the community: the Alberta clinical trial in optimizing hypertension (RxACTION). Can Pharm J. 2014;147:S18.
Rosenthal M, Tsuyuki R. A community-based approach to dyslipidemia management: pharmacist prescribing to achieve cholesterol targets (RxACT Study). Can Pharm J. 2014;147(4):S20.
Al Hamarneh Y, Sauriol L, Tsuyuki R. Economic analysis of the RxING study. Can Pharm J. 2014;147:S47.
Latter S, Blenkinsopp A, Smith A, Chapman S, Tinelli M, Gerard K, et al. Evaluation of nurse and pharmacist independent prescribing. London: Department of Health; 2010.
Alsulami Z, Conroy S, Choonara I. Medication errors in the Middle East countries: a systematic review of the literature. Eur J Clin Pharmacol. 2013;69(4):995–1008.
pubmed: 23090705
Aspden P, Wolcott J, Bootman JL, Cronenwett LR. Preventing medication errors. Washington: National Academies Press; 2007.
Avery AJ, Ghaleb M, Barber N, Franklin BD, Armstrong SJ, Serumaga B, et al. The prevalence and nature of prescribing and monitoring errors in English general practice: a retrospective case note review. Brit J Gen Pract. 2013;63(613):543–53.
Barber N, Rawlins M, Dean FB. Reducing prescribing error: competence, control, and culture. Qual Saf Health Care. 2003;12:29–32.
Ross S, Bond C, Rothnie H, Thomas S, Macleod MJ. What is the scale of prescribing errors committed by junior doctors? A systematic review. Brit J Clin Pharmacol. 2009;67:629–40.
Lewis PJ, Dornan T, Taylor D, Tully MP, Wass V, Ashcroft DM. Prevalence, incidence and nature of prescribing errors in hospital inpatients: a systematic review. Drug Saf. 2009;32:379–89.
pubmed: 19419233
Davies J, Horne R, Bennett J, Stott R. Doctors, pharmacists and the prescribing process. Br J Hosp Med. 1994;52:167–70.
pubmed: 8000681
Hindmarsh K. Optimal drug therapy: the role of the pharmacist in bridging the gap between knowledge and action. Can J Clin Pharmacol. 2001;8(Suppl A):53A–4A.
pubmed: 11586381
National Health Strategy 2018–2022. Ministry of Public Health, Qatar; 2017.
Sperry M, Pace H, Sawkin M, Ralston E, Deppe S. Student perspectives on prescriptive authority. Curr Pharm Teach Learn. 2014;6(6):834–41.
Creswell J, Clark V. Choosing a mixed method design. In: Creswell JW, Plano Clark VL, editors. Designing and conducting mixed method research. Thousand Oaks: SAGE Inc; 2006. p. 58–88.
Pluye P, Hong QN. Combining the power of stories and the power of numbers: mixed methods research and mixed studies reviews. Annu Rev Public Health. 2014;35:29–45.
pubmed: 24188053
Hadi MA, Closs SJ. Applications of mixed-methods methodology in clinical pharmacy research. Int J Clin Pharm. 2016;38(3):635–40.
pubmed: 26659085
20 Years of Helping Australians Make Better Decisions About Medicines. NPS MedicineWise. Prescribing Competencies Framework. 2012. https://www.nps.org.au/prescribing-competencies-framework . Accessed 30 May 2019.
Prescribing Competency Framework. 2016. https://www.rpharms.com/resources/frameworks/prescribers-competency-framework . Accessed 30 May 2019.
Guide to Good Prescribing: A Practical Manual. World health Organization. 1994. http://apps.who.int/medicinedocs/en/d/Jwhozip23e/ . Accessed 30 May 2019.
Brinkman D, Tichelaar J, Schutte T, Benemei S, Böttiger Y, Chamontin B, et al. Essential competencies in prescribing: a first European cross-sectional study among 895 final-year medical students. Clin Pharmacol Ther. 2016;101(2):281–9.
pubmed: 27648725
pmcid: 5260337
Sperry ML, Pace HA, Sawkin MT, Ralston EA, Deppe SS. Student perspectives on prescriptive authority. Curr Pharm Teach Learn. 2014;6:834–41.
Ross S, Maxwell S. Prescribing and the core curriculum for tomorrows doctors: BPS curriculum in clinical pharmacology and prescribing for medical students. Brit J Clin Pharmacol. 2012;74(4):644–61.
Emmerton L, Marriott J, Bessell T, Nissen L, Dean L. Pharmacists and prescribing rights: review of international developments. J Pharm Pharm Sci. 2005;8(2):217–25.
pubmed: 16124933
Lum E, Mitchell C, Coombes I. The competent prescriber: 12 core competencies for safe prescribing. Aust Prescr. 2013;36(1):13–6.
Cope LC, Abuzour AS, Tully MP. Non-medical prescribing: where are we now? Ther Adv Drug Saf. 2016;7(4):165–72.
pubmed: 27493720
pmcid: 4959632
Cooper R, Anderson C, Avery T, Bissell P, Guillaume L, Hutchinson A, et al. Stakeholders’ views of UK nurse and pharmacist supplementary prescribing. J Health Serv Res Policy. 2008;13(4):215–21.
pubmed: 18806179
Mccann L, Haughey S, Parsons C, Lloyd F, Crealey G, Gormley GJ, et al. Pharmacist prescribing in Northern Ireland: a quantitative assessment. Int J Clin Pharm. 2011;33(5):824–31.
pubmed: 21830075
Sandilands E, Reid K, Shaw L, Bateman D, Webb D, Dhaun N, et al. Impact of a focussed teaching programme on practical prescribing skills among final year medical students. Brit J Clin Pharmacol. 2010;71(1):29–33.
Rosenthal M, Austin Z, Tsuyuki RT. Are pharmacists the ultimate barrier to pharmacy practice change? Can Pharm J. 2010;143:37–42.
McIntosh T, Munro K, McLay J, Stewart D. A cross sectional survey of the views of newly registered pharmacists in Great Britain on their potential prescribing role: a cautious approach. Brit J Clin Pharmacol. 2012;73(4):656–60.
Bissell P, Cooper R, Guillaume L, Anderson C, Avery A, Hutchinson A, et al. An evaluation of supplementary prescribing in nursing and pharmacy. London: Department of Health; 2008.
George J, McCaig D, Bond C, Cunningham S, Diack L, Watson A, et al. Supplementary prescribing: early experiences of pharmacists in Great Britain. Ann Pharmacother. 2006;40:1843–50.
pubmed: 16968824
Dapar MLP, McCaig DJ, Cunningham ITS, Diack L, Stewart DC. Facilitators and barriers to pharmacist prescribing: exploring the association of pharmacy practice setting. Int J Pharm Pract. 2010;18:38.
Courtenay M, Carey N. Nurse independent prescribing and nurse supplementary prescribing practice: national survey. J Adv Nurs. 2008;61:291–9.
pubmed: 18197863
George J, Pfleger DE, McCaig DJ, Bond CM, Stewart DC. Independent prescribing by pharmacists: a study of the awareness, views and attitudes of Scottish community pharmacists. Pharm World Sci. 2006;28:45–53.
pubmed: 16752193
Hoti K, Sunderland B, Hughes J, Parsons R. An evaluation of Australian pharmacists attitudes on expanding their prescribing role. Pharm World Sci. 2010;32:610–21.
pubmed: 20683674
Neubauer SL, Suveges LG, Phillips KA, Kolodziejak LR. Competency assessment of pharmacists providing emergency contracep-tion. Can Pharm J. 2004;137:28–33.
Rosenthal M, Sutton J, Austin Z, Tsuyuki R. Relationship between personality traits and pharmacist performance in a pharmacy practice research trial. Can Pharm J. 2015;148(4):209–16.
Weng YH, Kuo KN, Yang CY, Lo HL, Chen C, Chiu YW. Implementation of evidence-based practice across medical, nursing, pharmacological and allied healthcare professionals: a questionnaire survey in nationwide hospital settings. Implement Sci. 2013;8:112.
pubmed: 24063756
pmcid: 3849261
Frankel GEC, Austin Z. Responsibility and confidence; identifying barriers to advanced pharmacy practice. Can Pharm J. 2013;146:155–61.
AMA takes strong stance on non-medical prescribing. Australian Medical Association. 2012. https://ama.com.au/media/ama-takes-strong-stance-non-medical-prescribing . Accessed 30 May 2019.
Mackay B. CMA frowns on prescribing rights for pharmacists. Can Med Assoc J. 2003;168(1):77.
Cotton R. Could independent pharmacist prescribing be a risk to our reputation? Pharm J. 2006;276:38.
Lloyd F, Parsons C, Hughes C. ‘It’s showed me the skills that he has’: pharmacists’ and mentors’ views on pharmacist supplementary prescribing. Int J Pharm Pract. 2010;18(1):29–36.
pubmed: 20405593
Charrois T, Rosenthal M, Ross Tsuyuki R. Stories from the trenches: experiences of Alberta pharmacists in obtaining additional prescribing authority. Can Pharm J. 2012;145:30–4.
El-Awaisi A, El Hajj MS, Joseph S, Diack L. Perspectives of pharmacy students in Qatar toward interprofessional education and collaborative practice: a mixed methods study. J Interprof Care. 2018;32(6):674–88.